𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New therapies for chronic hepatitis C virus infection

✍ Scribed by Anouk Dev; Keyur Patel; John G. McHutchison

Book ID
107538063
Publisher
Springer
Year
2004
Tongue
English
Weight
542 KB
Volume
6
Category
Article
ISSN
1522-8037

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New therapies for hepatitis C
New therapies for hepatitis C
✍ Apurva A. Modi; Jay H. Hoofnagle πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 57 KB

See Articles on Pages 631 and 640. N o challenge in clinical hepatology is as great today as the management of patients with chronic hepatitis C who have failed to respond to an adequate course of antiviral therapy. At present, the optimal regimen is a combination of peginterferon and ribavirin. 1 W

Pegylated interferon and ribavirin thera
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-SaunΓ©; J.P. Vinel; L. A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated